ALCAM and breast carcinoma: In various neoplasms like malignant melanoma [5], prostate cancer [6], colorectal carcinoma [7], bladder cancer [8] and breast cancer [9] as well as in oral [10] and esophageal squamous cell cancer [11] a pathologically altered ALCAM expression has been observed and was associated with cancer progression.